Commentary
Clinical Pharmacology & Therapeutics (2007) 82, 376–378. doi:10.1038/sj.clpt.6100349
Molecular Medicine: How, What, and When?
J Woodcock1
1Food and Drug Administration, Rockville, Maryland, USA
Correspondence: J Woodcock, (Janet.woodcock@fda.hhs.gov)
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in TranslationClinical Pharmacology & Therapeutics News and Views
